Topical cyclosporine administration in rabbits

L. M. Stokar, G. J. Burckart, M. D'Souza, Bernard A Cohen, R. Venkataramanan

Research output: Contribution to journalArticle

Abstract

Cyclosporine (CyA) is a potent immunosuppressant, but possesses toxicities which prohibit its unrestricted dosing in patients. The topical administration of CyA could serve to localize the immunosuppressive effect, or could serve as an administration route for patients who cannot tolerate the oral route of administration. We evaluated the potential for transdermal delivery of cyclosporine in rabbits. We sensitized six rabbits to dinitrochlorobenzene (DNCB), treated them topically with either 100 mg CyA or the vehicle, and repeated the DNCB skin testing at 15 and 28 days at the site of administration and at a distal site. In the CyA treated rabbits, significant increases in the suppression of the reaction to DNCB were observed from the control to the 15 day test, and from the 15 to the 28 day testing. Significant differences were also observed between reaction to DNCB at the site of CyA administration and at the distal site. While blood concentrations demonstrated slow and variable absorption of the topically administered CyA, concentrations >1000 ng/ml were frequently observed in blood. We conclude that the local versus a systemic dermatologic effect of CyA can be achieved, and that high blood concentrations are present after topical CyA administration in this model.

Original languageEnglish (US)
Pages (from-to)117-120
Number of pages4
JournalResearch Communications in Chemical Pathology and Pharmacology
Volume68
Issue number1
StatePublished - 1990
Externally publishedYes

Fingerprint

Topical Administration
Dinitrochlorobenzene
Cyclosporine
Rabbits
Immunosuppressive Agents
Blood
Oral Administration
Testing
Skin
Toxicity

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Stokar, L. M., Burckart, G. J., D'Souza, M., Cohen, B. A., & Venkataramanan, R. (1990). Topical cyclosporine administration in rabbits. Research Communications in Chemical Pathology and Pharmacology, 68(1), 117-120.

Topical cyclosporine administration in rabbits. / Stokar, L. M.; Burckart, G. J.; D'Souza, M.; Cohen, Bernard A; Venkataramanan, R.

In: Research Communications in Chemical Pathology and Pharmacology, Vol. 68, No. 1, 1990, p. 117-120.

Research output: Contribution to journalArticle

Stokar, LM, Burckart, GJ, D'Souza, M, Cohen, BA & Venkataramanan, R 1990, 'Topical cyclosporine administration in rabbits', Research Communications in Chemical Pathology and Pharmacology, vol. 68, no. 1, pp. 117-120.
Stokar, L. M. ; Burckart, G. J. ; D'Souza, M. ; Cohen, Bernard A ; Venkataramanan, R. / Topical cyclosporine administration in rabbits. In: Research Communications in Chemical Pathology and Pharmacology. 1990 ; Vol. 68, No. 1. pp. 117-120.
@article{86700963bf4b4dab87f551acda517277,
title = "Topical cyclosporine administration in rabbits",
abstract = "Cyclosporine (CyA) is a potent immunosuppressant, but possesses toxicities which prohibit its unrestricted dosing in patients. The topical administration of CyA could serve to localize the immunosuppressive effect, or could serve as an administration route for patients who cannot tolerate the oral route of administration. We evaluated the potential for transdermal delivery of cyclosporine in rabbits. We sensitized six rabbits to dinitrochlorobenzene (DNCB), treated them topically with either 100 mg CyA or the vehicle, and repeated the DNCB skin testing at 15 and 28 days at the site of administration and at a distal site. In the CyA treated rabbits, significant increases in the suppression of the reaction to DNCB were observed from the control to the 15 day test, and from the 15 to the 28 day testing. Significant differences were also observed between reaction to DNCB at the site of CyA administration and at the distal site. While blood concentrations demonstrated slow and variable absorption of the topically administered CyA, concentrations >1000 ng/ml were frequently observed in blood. We conclude that the local versus a systemic dermatologic effect of CyA can be achieved, and that high blood concentrations are present after topical CyA administration in this model.",
author = "Stokar, {L. M.} and Burckart, {G. J.} and M. D'Souza and Cohen, {Bernard A} and R. Venkataramanan",
year = "1990",
language = "English (US)",
volume = "68",
pages = "117--120",
journal = "Research Communications in Molecular Pathology and Pharmacology",
issn = "0034-5164",
publisher = "PJD Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Topical cyclosporine administration in rabbits

AU - Stokar, L. M.

AU - Burckart, G. J.

AU - D'Souza, M.

AU - Cohen, Bernard A

AU - Venkataramanan, R.

PY - 1990

Y1 - 1990

N2 - Cyclosporine (CyA) is a potent immunosuppressant, but possesses toxicities which prohibit its unrestricted dosing in patients. The topical administration of CyA could serve to localize the immunosuppressive effect, or could serve as an administration route for patients who cannot tolerate the oral route of administration. We evaluated the potential for transdermal delivery of cyclosporine in rabbits. We sensitized six rabbits to dinitrochlorobenzene (DNCB), treated them topically with either 100 mg CyA or the vehicle, and repeated the DNCB skin testing at 15 and 28 days at the site of administration and at a distal site. In the CyA treated rabbits, significant increases in the suppression of the reaction to DNCB were observed from the control to the 15 day test, and from the 15 to the 28 day testing. Significant differences were also observed between reaction to DNCB at the site of CyA administration and at the distal site. While blood concentrations demonstrated slow and variable absorption of the topically administered CyA, concentrations >1000 ng/ml were frequently observed in blood. We conclude that the local versus a systemic dermatologic effect of CyA can be achieved, and that high blood concentrations are present after topical CyA administration in this model.

AB - Cyclosporine (CyA) is a potent immunosuppressant, but possesses toxicities which prohibit its unrestricted dosing in patients. The topical administration of CyA could serve to localize the immunosuppressive effect, or could serve as an administration route for patients who cannot tolerate the oral route of administration. We evaluated the potential for transdermal delivery of cyclosporine in rabbits. We sensitized six rabbits to dinitrochlorobenzene (DNCB), treated them topically with either 100 mg CyA or the vehicle, and repeated the DNCB skin testing at 15 and 28 days at the site of administration and at a distal site. In the CyA treated rabbits, significant increases in the suppression of the reaction to DNCB were observed from the control to the 15 day test, and from the 15 to the 28 day testing. Significant differences were also observed between reaction to DNCB at the site of CyA administration and at the distal site. While blood concentrations demonstrated slow and variable absorption of the topically administered CyA, concentrations >1000 ng/ml were frequently observed in blood. We conclude that the local versus a systemic dermatologic effect of CyA can be achieved, and that high blood concentrations are present after topical CyA administration in this model.

UR - http://www.scopus.com/inward/record.url?scp=0025228567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025228567&partnerID=8YFLogxK

M3 - Article

VL - 68

SP - 117

EP - 120

JO - Research Communications in Molecular Pathology and Pharmacology

JF - Research Communications in Molecular Pathology and Pharmacology

SN - 0034-5164

IS - 1

ER -